Atopic dermatitis (AD) – a chronic skin condition marked by rashes, itching, and dryness – often goes beyond just physical discomfort. Many people with AD experience significant disruptions to sleep, focus, and mental well-being. The problem is that many patients settle for “good enough” symptom management, when more effective solutions exist.
The Hidden Costs of Untreated AD
While topical treatments can offer temporary relief, they don’t always address the underlying inflammation driving the disease. This can lead to frequent flares, persistent discomfort, and a negative impact on daily life. Research confirms this: severe AD is linked to decreased productivity and increased mental health burdens. For professionals, this means struggling to mask symptoms while maintaining performance.
Recognizing When Treatment Is Failing
The first step toward better management is identifying when your current approach isn’t working. Signs include:
- Increasingly frequent or prolonged flares.
- Symptoms that don’t respond to consistent topical therapies.
- Sleep disruption due to severe itching.
- Cracked, infected skin from scratching.
- Unmanageable side effects from existing medications.
Additionally, if AD is undermining your confidence, focus, or professional life, it’s time to re-evaluate your treatment plan. Keeping a detailed symptom diary – including physical symptoms, sleep quality, and work performance – can provide valuable insights for your dermatologist.
Shared Decision-Making for Optimal Outcomes
Patients don’t have to accept incomplete symptom control. If you’re considering a treatment switch, prepare specific questions for your next appointment. For example:
- Is clear skin a realistic goal, or just reduced itching?
- What alternative medications exist, including options like JAK inhibitors?
- What are the expected timelines for improvement with new treatments?
- What are the common and rare side effects to watch for?
- Is a long-term solution possible with oral therapies?
- What lifestyle adjustments complement medication?
New Options and Considerations
Oral therapies, such as JAK inhibitors, offer a more aggressive approach to stopping the itch-scratch cycle and controlling chronic inflammation. However, not everyone is a candidate. Always discuss these options with your dermatologist to determine if they’re appropriate for your condition.
The Bottom Line
Settling for “good enough” AD management can take a toll on both your physical and mental health. By tracking symptoms, asking the right questions, and considering advanced treatments, you can move beyond chronic discomfort and regain control of your well-being.
Sources:
LeBovidge JS et al. Depression and Anxiety in Patients with Atopic Dermatitis. Annals of Allergy, Asthma & Immunology. May 2025.
Naik H et al. Work Productivity Loss and Health-Related Quality of Life in People Living with Atopic Dermatitis: A Canada-Wide Cross-Sectional Study. Dermatitis: Contact, Atopic, Occupational, Drug. November 26, 2025.
Shawky AM et al. A Comprehensive Overview of Globally Approved JAK Inhibitors. Pharmaceutics. May 6, 2022.
Ludmann P. Eczema Types: Atopic Dermatitis Diagnosis and Treatment. American Academy of Dermatology Association. September 24, 2025.
